Treatment with either leflunomide or adalimumab reduces anaemia in patients with rheumatoid arthritis

Autor: Mahiba M R S Martins, Ione C. P. Pereira, Thayanne França Muniz, Anita Maria da Rocha Fernandes, Bruna L.R. Silva, Valderlane L. P. Colares, Nágila Caroline Fialho Sousa, Domingos M. S. Pereira, Saulo J. F. Mendes, Cinara R A V Monteiro, Elizabeth S. Fernandes

Publikováno v: Anais da Academia Brasileira de Ciências v.90 n.2 suppl.1 2018
Anais da Academia Brasileira de Ciências
Academia Brasileira de Ciências (ABC)
instacron:ABC
Anais da Academia Brasileira de Ciências, Vol 90, Iss 2 suppl 1, Pp 2161-2166 (2018)
Anais da Academia Brasileira de Ciências, Volume: 90, Issue: 2 Supplement 1, Pages: 2161-2166, Published: 25 JUN 2018
Anais da Academia Brasileira de Ciências, Issue: ahead, Published: 25 JUN 2018

Rheumatoid arthritis is a chronic disease of the joints, which causes joint pain and disability. Anaemia is a frequent extra-articular manifestation in rheumatoid arthritis, affecting 30-70% of the patients; presenting a negative impact on patient´s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3deefbdf6dfc3046d89440ef02df86a
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652018000502161